Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Meyer Handelman Co. increased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 11.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,235 shares of the biopharmaceutical company’s stock after purchasing an additional 435 shares during […]
Meyer Handelman Co. lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 11.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 4,235 shares of the biopharmaceutical company’s stock after acquiring an additional 435 shares during the quarter. Meyer Handelman Co.’s holdings […]
Jackson Creek Investment Advisors LLC cut its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 9.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 696 shares of the biopharmaceutical company’s stock after selling 76 shares during the quarter. Jackson Creek Investment […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target boosted by equities researchers at Barclays from $935.00 to $1,020.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Barclays‘s target price indicates a potential upside of 8.18% from the company’s previous […]
Machina Capital S.A.S. bought a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 722 shares of the biopharmaceutical company’s stock, valued at approximately $594,000. Other hedge funds and other institutional investors […]